These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 1618253)

  • 1. Effect of salbutamol on digoxin pharmacokinetics.
    Edner M; Jogestrand T; Dahlqvist R
    Eur J Clin Pharmacol; 1992; 42(2):197-201. PubMed ID: 1618253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of salbutamol on digoxin concentration in serum and skeletal muscle.
    Edner M; Jogestrand T
    Eur J Clin Pharmacol; 1989; 36(3):235-8. PubMed ID: 2744063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral salbutamol decreases serum digoxin concentration.
    Edner M; Jogestrand T
    Eur J Clin Pharmacol; 1990; 38(2):195-7. PubMed ID: 2338119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of adrenaline and mental stress on serum digoxin concentration.
    Edner M; Hjemdahl P; Jogestrand T; Ljunghall S
    J Cardiovasc Pharmacol; 1991 Feb; 17(2):325-31. PubMed ID: 1709239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta
    Hostrup M; Reitelseder S; Jessen S; Kalsen A; Nyberg M; Egelund J; Kreiberg M; Kristensen CM; Thomassen M; Pilegaard H; Backer V; Jacobson GA; Holm L; Bangsbo J
    J Physiol; 2018 Sep; 596(17):4121-4139. PubMed ID: 29968301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and extrapulmonary beta 2 adrenoceptor activity of nebulised racemic salbutamol and its R and S isomers in healthy volunteers.
    Lipworth BJ; Clark DJ; Koch P; Arbeeny C
    Thorax; 1997 Oct; 52(10):849-52. PubMed ID: 9404370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salbutamol induced hypokalaemia: the effect of theophylline alone and in combination with adrenaline.
    Whyte KF; Reid C; Addis GJ; Whitesmith R; Reid JL
    Br J Clin Pharmacol; 1988 May; 25(5):571-8. PubMed ID: 3408637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of digoxin and main metabolites/derivatives in healthy humans.
    Hinderling PH; Hartmann D
    Ther Drug Monit; 1991 Sep; 13(5):381-401. PubMed ID: 1957331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of beta-adrenoceptor subtype mediating the metabolic actions of salbutamol.
    Berend N; Marlin GE
    Br J Clin Pharmacol; 1978 Mar; 5(3):207-11. PubMed ID: 207295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mechanism of salbutamol-induced hypokalaemia.
    Whyte KF; Addis GJ; Whitesmith R; Reid JL
    Br J Clin Pharmacol; 1987 Jan; 23(1):65-71. PubMed ID: 3545273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of intravenous and oral salbutamol and its sulphate conjugate.
    Morgan DJ; Paull JD; Richmond BH; Wilson-Evered E; Ziccone SP
    Br J Clin Pharmacol; 1986 Nov; 22(5):587-93. PubMed ID: 3790406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The metabolic actions of intravenous salbutamol and aminophylline singly and in combination.
    Jenkins CR; Marlin GE
    Br J Clin Pharmacol; 1981 Feb; 11(2):197-201. PubMed ID: 7011349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skeletal muscle digoxin concentration and its relation to serum digoxin concentration and cardiac effect in healthy man.
    Jogestrand T; Sundqvist K
    Eur J Clin Pharmacol; 1981 Jan; 19(2):89-95. PubMed ID: 7202476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of physical exercise on the pharmacokinetics of digoxin during maintenance treatment.
    Jogestrand T; Andersson K
    J Cardiovasc Pharmacol; 1989 Jul; 14(1):73-6. PubMed ID: 2475719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction and dose equivalence of salbutamol and salmeterol in patients with asthma.
    Smyth ET; Pavord ID; Wong CS; Wisniewski AF; Williams J; Tattersfield AE
    BMJ; 1993 Feb; 306(6877):543-5. PubMed ID: 8096416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of the effects of salbutamol by propranolol and atenolol.
    Minton NA; Baird AR; Henry JA
    Eur J Clin Pharmacol; 1989; 36(5):449-53. PubMed ID: 2753063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of beta 2-adrenoceptor agonists on plasma potassium and cardiopulmonary responses on exercise in patients with chronic obstructive pulmonary disease.
    Yang CT; Lin HC; Lin MC; Wang CH; Lee CH; Kuo HP
    Eur J Clin Pharmacol; 1996; 49(5):341-5. PubMed ID: 8866625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time course and relative dose potency of systemic effects from salmeterol and salbutamol in healthy subjects.
    Bennett JA; Tattersfield AE
    Thorax; 1997 May; 52(5):458-64. PubMed ID: 9176539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The extrapulmonary effects of inhaled hexoprenaline and salbutamol in healthy individuals.
    Bremner P; Burgess C; Purdie G; Beasley R; Crane J
    Eur J Clin Pharmacol; 1993; 45(1):37-9. PubMed ID: 8405027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective study of the effects of prolonged timolol therapy on alpha- and beta-adrenoceptor and angiotensin II receptor mediated responses in normal subjects.
    Ferro A; Hall JA; Dickerson JE; Brown MJ
    Br J Clin Pharmacol; 1997 Mar; 43(3):301-8. PubMed ID: 9088585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.